TARO PHARMACEUTICAL INDUSTRIES LTD - SHS (TARO)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SHS
Shares, excl. options Q1 2024
4.46 M
Holdings value Q1 2024
$189 M
Value change Q1 2024
-$8.18 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
68
Number of buys Q1 2024
38
Number of sells Q1 2024
-36
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
M8737E108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 4.46 M $189 M -$8.18 M $42.34 69
2023 Q4 4.79 M $200 M +$291 K $41.78 83
2023 Q3 4.85 M $183 M +$3.07 M $37.71 78
2023 Q2 4.67 M $177 M +$26.2 M $37.93 67
2023 Q1 4.14 M $101 M -$1.46 M $24.32 58
2022 Q4 3.84 M $111 M -$9.53 M $29.04 53
2022 Q3 4.15 M $124 M -$734 K $29.98 54
2022 Q2 3.93 M $142 M -$5.72 M $36.16 61
2022 Q1 4.36 M $189 M -$2.86 M $43.26 55
2021 Q4 4.34 M $217 M +$594 K $50.11 63
2021 Q3 4.61 M $293 M -$10.1 M $63.63 68
2021 Q2 4.76 M $343 M -$12.5 M $71.96 74
2021 Q1 4.84 M $357 M -$13.4 M $73.75 78
2020 Q4 5.03 M $369 M +$21 M $73.42 80
2020 Q3 4.68 M $256 M +$1.39 M $54.85 72
2020 Q2 4.73 M $314 M +$9.12 M $66.49 78
2020 Q1 4.62 M $283 M +$6.56 M $61.20 84
2019 Q4 4.4 M $385 M +$15.8 M $87.93 92
2019 Q3 4.18 M $314 M +$7.47 M $75.45 96
2019 Q2 4.08 M $346 M +$20.8 M $85.42 99
2019 Q1 4.05 M $435 M +$16.5 M $108.09 98
2018 Q4 3.87 M $325 M -$39.9 M $84.64 85
2018 Q3 4.28 M $418 M -$5.29 M $98.30 105
2018 Q2 4.3 M $492 M +$11.2 M $115.69 99
2018 Q1 4.53 M $443 M -$47.3 M $98.74 103
2017 Q4 4.97 M $516 M -$80 M $104.71 119
2017 Q3 5.61 M $632 M -$40.2 M $112.69 127
2017 Q2 5.97 M $669 M -$24.4 M $112.06 135
2017 Q1 6.02 M $705 M -$34.9 M $116.62 129
2016 Q4 6.81 M $715 M -$57.9 M $105.27 144
2016 Q3 7.38 M $815 M +$43.9 M $110.51 155
2016 Q2 6.9 M $1 B +$176 M $145.60 153
2016 Q1 5.75 M $822 M -$7.48 M $143.25 162
2015 Q4 5.8 M $896 M +$126 M $154.55 151
2015 Q3 4.89 M $698 M +$20.7 M $142.89 115
2015 Q2 4.73 M $679 M -$42.5 M $143.69 100
2015 Q1 4.96 M $701 M -$20.6 M $141.03 94
2014 Q4 5.05 M $750 M -$26 M $148.19 87
2014 Q3 4.28 M $658 M -$27.1 M $153.86 79
2014 Q2 4.46 M $625 M +$98.9 M $140.24 71
2014 Q1 4.04 M $449 M -$14.1 M $111.00 65